SCHEMBL25566842

SCHEMBL25566842

COC(CO)C(O)C(O)n1cnc2c(NCCc3ccccc3)ncnc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 8/20 0.54
▸ ADORA1 P30542 7/20 0.54
▸ TMIGD3 P0DMS9 4/20 0.54
▸ ADORA2B P29275 3/20 0.54
▸ CDK1 P06493 5/20 0.50
▸ CCNB2 O95067 4/20 0.50
▸ CCNB1 P14635 4/20 0.50
▸ CCNB3 Q8WWL7 4/20 0.50
▸ CDK2 P24941 1/20 0.50
▸ ADORA3 P0DMS8 4/20 0.49
▸ NFKB1 P19838 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ THPO P40225 1/20 0.49
▸ HTT P42858 1/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NR2F2 P24468 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27430176 0.90 CDK1 (0.63) ADORA2AADORA1TMIGD3CDK1CCNB2
SCHEMBL24722333 0.81 CCNB2 (0.41) ADORA2AADORA1CDK1CCNB2CCNB1
SCHEMBL22214990 0.77 CDK1 (0.55) ADORA2AADORA1TMIGD3CDK1CCNB2
SCHEMBL20008058 0.77 CDK1 (0.55) ADORA2AADORA1TMIGD3CDK1CCNB2
SCHEMBL21450235 0.76 NT5E (0.54) ADORA2AADORA1TMIGD3CDK1CCNB2
SCHEMBL21540715 0.74 FDPS (0.39) ADORA2AADORA1ADORA2BCDK1CCNB2
SCHEMBL24220583 0.74 ADORA1 (0.51) ADORA2AADORA1ADORA3NFKB1THPO
SCHEMBL19370351 0.72 NT5E (0.50) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL23046742 0.72 CCNB2 (0.39) ADORA2AADORA1CDK1CCNB2CCNB1
SCHEMBL20857311 0.72 CCNB2 (0.39) ADORA2AADORA1CDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091791-A1 METHODS OF TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS ASTROCYTE PHARMACEUTICALS, INC. (US) 2023-05-25 — — WO disclosed
Send feedback